Skip to main content
Premium Trial:

Request an Annual Quote

WuXi NextCode Sequencing Facility Receives CAP Accreditation

NEW YORK (GenomeWeb) –WuXi AppTec subsidiary WuXi NextCode said today that its sequencing facility in Shanghai, China has been accredited by the College of American Pathologists.

The company also said that the Shanghai lab is the first such lab in China to be licensed by the State of California, allowing the company to process samples from the state. WuXi NextCode is also the only sequencing facility in China with CLIA certification from the US Centers for Medicare and Medicaid, the company said.

"Our system is the emerging global standard for querying, storing and collaborating with genomic data," WuXi NextCode COO Hannes Smarason said in a statement. "The CAP, CLIA and California accreditation of our sequencing lab ... [enables] us to provide products and services to more customers and to the most demanding standards in every market."

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.